Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice

Experimental Biology and Medicine

Volumn 233, Issue 11, 2008, Pages 1421-1432

  Kumar, Srinivasan Dinesh ^a   Yong, Sook Kwin ^a   Dheen, S Thameem ^a   Bay, Boon Huat ^a   Tay, Samuel Sam Wah ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Developing heart; ENOS; H9C2 cell line; Maternal diabetes; Mice; VEGF

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; MESSENGER RNA; NITRIC OXIDE; VASCULOTROPIN; NITRIC OXIDE SYNTHASE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VACUOLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE MODEL; EMBRYO; FEMALE; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HYPERGLYCEMIA; IN VITRO STUDY; MALE; MATERNAL DIABETES MELLITUS; MOUSE; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; RIBOSOME; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; EMBRYO DEVELOPMENT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART; HEART MUSCLE; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT; RAT; ULTRASTRUCTURE;

MUS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; EMBRYONIC DEVELOPMENT; FEMALE; GLUCOSE; HEART; HEART DEFECTS, CONGENITAL; MICE; MYOBLASTS, CARDIAC; MYOCARDIUM; NITRIC OXIDE SYNTHASE; RATS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58249091209     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0806-RM-186     Document Type: Article

References (48)

1. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 315:279-281, 1997.
2. Kuhl C, Coustan D, Kitzmiller J, Philipps A, Binder C, Schneider H. Report on the 28th annual meeting of the Diabetic Pregnancy Study Group. Diabetologia 41:suppl 8-14, 1998.
3. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43:79-82, 2000.
4. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61:85-95, 2001.
5. Lazarow A, Kim JN, Wells LJ. Birth weight and fetal mortality in pregnant subdiabetic rats. Diabetes 9:114-117, 1960.
6. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63:193-201, 2001.
7. Pedersen LM, Tygstrup I, Pedersen J. Congenital malformations in newborn infants of diabetic women. Correlation with maternal diabetic vascular complications. Lancet 1:1124-1126, 1964.
8. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 94:435-444, 2001.
9. Cockroft DL, Coppola PT. Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology 16:141-146, 1977.
10. Ellington SK. In-vivo and in-vitro studies on the effects of maternal fasting during embryonic organogenesis in the rat. J Reprod Fertil 60: 383-388, 1980.
11. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981.
12. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28:292-293, 1979.
13. Baker L, Piddington R, Goldman A, Egler J, Moehring J. Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596, 1990.
14. Eriksson UJ, Borg LA. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991.
15. Eriksson UJ, Borg LA. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993.
16. Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev Endocr Metab Disord 4:79-93, 2003.
17. Kumar SD, Dheen ST, Tay SS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 6:34, 2007.
18. Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7:259-270, 1996.
19. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23:1121-1131, 1994.
20. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A 90:347-351, 1993.
21. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J, Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43:675-684, 1999.
22. Feng Q, Song W, Lu X, Hamilton JA, Lei M, Peng T, Yee SP. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106:873-879, 2002.
23. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127:3941-3946, 2000.
24. Sissman NJ. Developmental landmarks in cardiac morphogenesis: comparative chronology. Am J Cardiol 25:141-148, 1970.
25. Kaufman MH. The Atlas of Mouse Development. New York: Academic Press, 1992.
26. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 98: 912-918, 1998.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408, 2001.
29. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population- based case-control study. Pediatrics 85:1-9, 1990.
30. Dinleyici EC, Tekin N, Dinleyici M, Kilic Z, Adapinar B, Aksit MA. Severe fatal course of axial mesodermal dysplasia spectrum associated with complex cardiac defect in an infant of a mother with insulin dependent diabetes. Am J Med Genet A 143:2156-2159, 2007.
31. Schafer K, Neuhaus P, Kruse J, Braun T. The homeobox gene Lbx1 specifies a subpopulation of cardiac neural crest necessary for normal heart development. Circ Res 92:73-80, 2003.
32. Ferencz C, Rubin JD, McCarter RJ, Clark EB. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 41:319-326, 1990.
33. Molin DG, Roest PA, Nordstrand H, Wisse LJ, Poelmann RE, Eriksson UJ, Gittenberger-De Groot AC. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol 70:927-938, 2004.
34. Smoak IW. Hyperglycemia-induced TGFbeta and fibronectin expression in embryonic mouse heart. Dev Dyn 231:179-189, 2004.
35. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231, 1997.
36. Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, Carmeliet P, Keshet E. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 128: 1531-1538, 2001.
37. Cooper RG, Taylor CM, Choo JJ, Weiss JB. Elevated endothelial-cell- stimulating angiogenic factor activity in rodent glycolytic skeletal muscles. Clin Sci (Lond) 81:267-270, 1991.
38. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104:2344-2350, 2001.
39. Williams B, Gallacher B, Patel H, Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497-1503, 1997.
40. Roguin A, Nitecki S, Rubinstein I, Nevo E, Avivi A, Levy NS, Abassi ZA, Sabo E, Lache O, Frank M, Hoffman A, Levy AP. Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovasc Diabetol 2:18, 2003.
41. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, Madri JA. Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160:605-615, 2003.
42. Hallaq H, Pinter E, Enciso J, McGrath J, Zeiss C, Brueckner M, Madri J, Jacobs HC, Wilson CM, Vasavada H, Jiang X, Bogue CW. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 131:5197-5209, 2004.
43. Watanabe M, Choudhry A, Berlan M, Singal A, Siwik E, Mohr S, Fisher SA. Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. Development 125:3809-3820, 1998.
44. Abdelwahid E, Pelliniemi LJ, Niinikoski H, Simell O, Tuominen J, Rahkonen O, Jokinen E. Apoptosis in the pattern formation of the ventricular wall during mouse heart organogenesis. Anat Rec 256:208-217, 1999.
45. Brune B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid Redox Signal 7:497-507, 2005.
46. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 24:31-41, 2007.
47. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia- induced apoptosis in mouse myocardium: mitochondrial cytochrome C- mediated caspase-3 activation pathway. Diabetes 51:1938-1948, 2002.
48. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50:1414-1424, 2001.